Literature DB >> 563400

Purification of interferon from mouse Ehrlich ascites tumor cells.

M Kawakita, B Cabrer, H Taira, M Rebello, E Slattery, H Weideli, P Lengyel.   

Abstract

Interferon production was induced in mouse Ehrlich ascites tumor cells by infection with Newcastle disease virus. The interferon produced was purified by precipitation with ammonium sulfate, chromatography on carboxymethyl-Sephadex, treatment with blue dextran and polyethylene glycol, gel filtration on Bio-Gel P-60 and Bio-Gel P-200, chromatography on phosphocellulose, isoelectric focusing, and chromatography on octyl-Sepharose. The specific activity of the product was 1.6 x 10(9) NIH mouse interferon reference standard units/mg of protein. Electrophoresis in polyacrylamide gels in the presence of sodium dodecyl sulfate indicated that the apparent molecular weight of the interferon-active material ranged from 25,000 to 35,000. As revealed by staining the gels with Coomassie brilliant blue, the interferon activity co-migrated with the major, broad protein band. Minor, stainable bands of proteins were free of interferon activity and their apparent molecular weight was smaller than 12,000.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 563400

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon.

Authors:  A Fuse; T Kuwata
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Specific protein phosphorylation in interferon-treated uninfected and virus-infected mouse L929 cells: enhancement by double-stranded RNA.

Authors:  S L Gupta
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

3.  Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.

Authors:  W E Stewart; T Chudzio; L S Lin; M Wiranowska-Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Biological detection of specific mRNA molecules by microinjection.

Authors:  C P Liu; D L Slate; R Gravel; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Purification and partial characterization of human lymphoblast interferon.

Authors:  K C Zoon; M E Smith; P J Bridgen; D zur Nedden; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Large-scale production and partial purification of mouse immune interferon.

Authors:  L C Osborne; J A Georgiades; H M Johnson
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

7.  Human leukocyte interferon: production, purification to homogeneity, and initial characterization.

Authors:  M Rubinstein; S Rubinstein; P C Familletti; R S Miller; A A Waldman; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

8.  Interferon action: induction of specific proteins in mouse and human cells by homologous interferons.

Authors:  S L Gupta; B Y Rubin; S L Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  Heterogeneity of interferon mRNA species from Sendai virus-induced human lymphoblastoid (Namalva) cells and Newcastle disease virus-induced murine fibroblastoid (L) cells.

Authors:  A D Sagar; L A Pickering; P Sussman-Berger; W E Stewart; P B Sehgal
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

10.  Large-scale production and physicochemical characterization of human immune interferon.

Authors:  M P Langford; J A Georgiades; G J Stanton; F Dianzani; H M Johnson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.